Skip to main content
SpringerLink
Log in

Trivalent or quadrivalent influenza vaccine better value for money?

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hendriks J, et al. Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability. Vaccine : Jun 2018. Available from: URL: http://doi.org/10.1016/j.vaccine.2018.05.099

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trivalent or quadrivalent influenza vaccine better value for money?. PharmacoEcon Outcomes News 806, 30 (2018). https://doi.org/10.1007/s40274-018-5073-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5073-1

Search

Navigation